We are live on ! Find out more
ITP

Iron Triangle Partners Portfolio holdings

AUM $875M
1-Year Est. Return 49.85%
This Fund
S&P 500
This Quarter Est. Return
+4.22%
1 Year Est. Return
+49.85%
3 Year Est. Return
+151.9%
5 Year Est. Return
+239.84%
10 Year Est. Return
–
AUM
$984M
AUM Growth
+$7.35M
Cap. Flow
+$19.2M
Cap. Flow %
1.95%
Top 10 Hldgs %
56.94%
Holding
39
New
10
Increased
11
Reduced
5
Closed
13

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$64.4M
2
INSP icon
Inspire Medical Systems
INSP
+$53.4M
3
PODD icon
Insulet
PODD
+$47.6M
4
DHR icon
Danaher
DHR
+$47.2M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$46.2M

Top Sells

Rank Stock Value
1
ICLR icon
Icon
ICLR
+$50.7M
2
EXAS
Exact Sciences
EXAS
+$48.3M
3
ALGN icon
Align Technology
ALGN
+$46.6M
4
ILMN icon
Illumina
ILMN
+$45.4M
5
BRKR icon
Bruker
BRKR
+$43.8M

Sector Composition

Rank Sector Weight
1 Healthcare 96.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALMS
26
Alumis Inc
ALMS
$3.45B
$1.66M 0.17%
+125,000
New +$1.66M
ALGN icon
27
Align Technology
ALGN
$12B
– –
-141,958
Closed -$46.6M
APLS
28
DELISTED
Apellis Pharmaceuticals
APLS
– –
-550,000
Closed -$32.3M
AVTR icon
29
Avantor
AVTR
$8.03B
– –
-1,150,000
Closed -$29.4M
BRKR icon
30
Bruker
BRKR
$9.14B
– –
-466,521
Closed -$43.8M
CYTK icon
31
Cytokinetics
CYTK
$10.9B
– –
-300,000
Closed -$21M
EXAS
32
DELISTED
Exact Sciences
EXAS
– –
-700,000
Closed -$48.3M
FTRE icon
33
Fortrea Holdings
FTRE
$1.82B
– –
-791,233
Closed -$31.8M
ICLR icon
34
Icon
ICLR
$13B
– –
-150,853
Closed -$50.7M
ILMN icon
35
Illumina
ILMN
$28.7B
– –
-340,019
Closed -$45.4M
NYXH
36
Nyxoah
NYXH
$140M
– –
-253,025
Closed -$3.41M
SNDX icon
37
Syndax Pharmaceuticals
SNDX
$1.82B
– –
-973,057
Closed -$23.2M
XBI icon
38
State Street SPDR S&P Biotech ETF
XBI
$10.2B
– –
-226,066
Closed -$21.5M
SWAV
39
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-79,736
Closed -$26M
1
2

Similar funds

8KM
8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return
MFG
MidWestOne Financial Group Iowa City, Iowa $900M AUM 23.95% 1-Year Est. Return
NP
Ninepoint Partners Toronto, Ontario, Canada $904M AUM 39.64% 1-Year Est. Return
GGI
Galaxy Group Investments New York $843M AUM 47.48% 1-Year Est. Return
WFAL
Wedbush Fund Advisers, LLC Pasadena, California $967M AUM
OBWP
O'Brien Wealth Partners Waltham, Massachusetts $756M AUM 13.93% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $693M AUM 17.6% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Iron Triangle Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Iron Triangle Partners held 39 positions worth $984M, up 0.75% from $976M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Iron Triangle Partners's Q2 2024 filing shows 10 new, 11 increased, 5 reduced and 13 closed positions. Its largest new stake was Edwards Lifesciences: 727,180 shares worth $67.2M. The largest sale was Icon, an estimated $50.7M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 97% a quarter earlier.

  • Iron Triangle Partners's largest Q2 2024 buy was Edwards Lifesciences: 727,180 shares worth $67.2M.
  • Iron Triangle Partners added most to Elanco Animal Health in Q2 2024, an estimated $30.9M increase.
  • Iron Triangle Partners's biggest Q2 2024 reduction was Acadia Healthcare, cutting an estimated $4.45M.
  • Iron Triangle Partners fully exited Icon in Q2 2024, selling an estimated $50.7M.
  • Iron Triangle Partners's ten largest holdings make up 57% of its $984M portfolio in Q2 2024.
  • Iron Triangle Partners opened 10 new positions and closed 13 in Q2 2024.
  • Iron Triangle Partners's portfolio value rose 0.75% quarter-over-quarter to $984M.

Based on Iron Triangle Partners's 13F filing for Q2 2024, filed 14 Aug 2024.